Programmed Multiresponsive Vesicles for Enhanced Tumor Penetration and Combination Therapy of Triple-Negative Breast Cancer

2017 ◽  
Vol 27 (20) ◽  
pp. 1606530 ◽  
Author(s):  
Fangyuan Zhou ◽  
Bing Feng ◽  
Tingting Wang ◽  
Dangge Wang ◽  
Qingshuo Meng ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Tumor Penetration

Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures

Biomaterials ◽  
2017 ◽  
Vol 113 ◽  
pp. 243-252 ◽  
Author(s):  
Yanping Ding ◽  
Shishuai Su ◽  
Ruirui Zhang ◽  
Leihou Shao ◽  
Yinlong Zhang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Core Shell ◽  
Shell Nanostructures

Abstract 1561: Age impacts response to paclitaxel-anti-PDL1 combination therapy in triple-negative breast cancer

2021 ◽  
Author(s):  
Milos Spasic ◽  
Gregory J. Goreczny ◽  
Qiuchen Guo ◽  
John N. Hutchinson ◽  
Rachel A. Freedman ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Triple Negative Breast Cancer ◽  
Triple Negative

scholarly journals Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy

2018 ◽  
Vol 25 (6) ◽  
pp. 1838-1850 ◽  
Author(s):  
Pierre Foidart ◽  
Cassandre Yip ◽  
Jean Radermacher ◽  
Silvia Blacher ◽  
Mehdi Lienard ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Triple Negative Breast Cancer ◽  
Triple Negative

scholarly journals MAPK4 silencing together with a PARP1 inhibitor as a combination therapy in triple‑negative breast cancer cells

2021 ◽  
Vol 24 (2) ◽  
Author(s):  
Xiaoqi Zeng ◽  
Shanshan Jiang ◽  
Simin Ruan ◽  
Zhaoze Guo ◽  
Jingyun Guo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative

scholarly journals Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer

Oncotarget ◽  
2016 ◽  
Vol 7 (45) ◽  
pp. 73618-73637 ◽  
Author(s):  
Abderrahim El Guerrab ◽  
Mahchid Bamdad ◽  
Fabrice Kwiatkowski ◽  
Yves-Jean Bignon ◽  
Frédérique Penault-Llorca ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Monoclonal Antibodies ◽  
Combination Therapy ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Triple Negative Breast Cancer ◽  
Kinase Inhibitors ◽  
Triple Negative ◽  
Egfr Tyrosine Kinase ◽  
Egfr Tyrosine Kinase Inhibitors

Abstract 2160: Targeting SMC1 in combination therapy for triple negative breast cancer

2016 ◽  
Author(s):  
Sushma Yadav ◽  
David Berz ◽  
George Somlo ◽  
Kimlin Ashing ◽  
Yate-Ching Yuan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Triple Negative Breast Cancer ◽  
Triple Negative
Sign in / Sign up

Export Citation Format

Share Document